Web Photo Album

Click Here

 

K A W IText Box: - Determined to Make a
 Difference -

Kenya AIDS Watch Institute


 

CALL THE AIDS HOTLINE NOW

 

 


Home

About Us

AIDS Hotline

News on HIV/AIDS

Upcoming Events

The Team

HIV Treatment

The Other War

KAWI statement on Zinc Supplement


OUR MOTTO

Every day, 700 Kenyans die of HIV/AIDS related diseases. AIDS is spreading rapidly. We join this war because "we are determined to make a difference."


A Ravaged Continent:

KAWI's brochure, depicting, among others South African AIDS Campaigner and victim Nkosi Johnson. Africa is the continent most affected by HIV/AIDS and the efforts made by organizations are paying dividends in alleviating the situation.

 

 

KAWI’s position on Zinc Supplement claims

 

Recently a Kenyan scientist, Mr Charles Mbakaya, claimed success in file search for an AIDS drug. He stated that the AIDS was not “all about sex” and added that there was “the nutrition angle to think about”. He drew parallels to South Africa President Thabo Mbeki’s assertion that “Africa should not wholly believe the Western view about medicine.”

From a purely political point of view, Mbeki’s standpoint is admirable to some, given the harsh history Africa has had with the West. However, this should not mean that HIV does not cause AIDS. In any case, last week it was reported that Mbeki now accepts the negative impact that the pandemic is having on South African society and the country’s image abroad, and pledged to reaffirm the official government position in support of the scientifically demonstrated link between HIV infection and AIDS.

Mbeki’s position notwithstanding, HIV does exist. And it is the cause of AIDS. AIDS stands for Acquired Immune Deficiency Syndrome. A patient is described as having AIDS when the immune system is so damaged that he has less than 200 CD4+ cells or gets opportunistic infections.

There is an “official” list of these infections, the most common being pneumocystis carinii pneumonia, a lung infection. There is also Karposi’s sarcoma, a skin cancer, Cytomegalovirus, an infection that usually affects the eyes, Candida, a fungal infection, Toxoplasmosis, a protozoal infection of the brain, and in over 50 per cent of the AIDS cases in Kenya, Tuberculosis, a bacterial infection that attacks the lungs, and can cause meningitis.

It is important to make clear the fact that there is no cure, neither is there any vaccination for HIV/AIDS.

AIDS is fatal. But while there is no cure, there are several forms of anti-retroviral medicines that if taken in the right combinations, do delay the progression of HIV infection to AIDS

Dr Martin Markowitz, Clinical Director at the Aaron Diamonds AIDS Research Centre in New York, says that these drugs have to be prescribed by trained medical personnel and the patient’s progress monitored if the drugs are to work.

Dr Markowitz was on an award-winning team that led to the development of Highly Active Anti-Retroviral Treatment. He has also been treating AIDS patients since 1981 and is involved in some of the most cutting edge AIDS-related research.

The research data presented by Mbakaya is preliminary and should therefore not be used for developing AIDS treatment policy before being subjected to a rigorous review process with the normal well-established protocol for clinical trials.

Such a study should be published in a reputable journal, as that would require it to be peer-reviewed on a stringent basis by virologists, pharmacists, biochemists and clinicians.

Even if this study has been published, the inherent weaknesses of the data presented still need to be addressed.

Indeed the immune system is adversely affected by even moderate degrees of zinc deficiency. Severe zinc deficiency results in severely depressed immune function and frequent infections.

Zinc is required for the development and activation of T-lymphocytes, a kind of white blood cell that helps fight infection. When zinc supplements are given to individuals with low zinc levels, the numbers of T-cell lymphocytes circulating in the blood increase and the ability of lymphocytes to fight infection improves. These are well known facts.

Dr Francis Kajumo, a Kenyan born researcher at the Albert Einstein School of Medicine in New York, US, and a director at the Kenya AIDS Watch Institute, says: “While there is a scientific basis to the claim that zinc boosts the immune system on a general basis, so do other chemicals and substances. None of them have been effective in reducing viral load on even a short term because this virus attacks the immune system itself and unless a zinc anti-viral effect and/or a negative interaction between zinc and the virus is proven any claims of a zinc-laden supplement reducing viral load in patients have no real basis”.

Kajumo adds: “Just boosting the immune system may just increase fresh host targets for the virus to replicate in, and by laws of attrition, the body fails to produce enough immune cells to destroy the virus than those that are killed and infected with HIV and so we have an increase in viral load.”

Questions have also been raised about Mbakaya’s study: who was eligible to participate in their trials? What criteria were used in selecting participants? What were their initial viral loads? What were the negative controls used? Were any efforts made to determine whether participants were on a zinc deficient diet prior to commencement of the study? Was the “double-blind method used?

The researcher should be willing to allow access to the patients them- selves to peers to verify that there has actually been a reduction of viral loads. Kajumo quotes the US’ National Institutes of Health guidelines.

“It is also very important to know what the amount of zinc given was in these supplements, because too much can cause toxicity and cause loss of immune function.”

There is a certain health risk to too much zinc. Zinc toxicity has been seen in both acute and chronic forms. Intakes of 150 to 450 mg of zinc per day have been associated with low copper status, altered iron function, reduced immune function, and reduced levels of high-density lipoproteins (the good cholesterol).

One case report cited severe nausea and vomiting within 30 minutes after the person ingested four grams of zinc gluconate (570 mg elemental zinc). Turning to the nutrition aspect, “if as Mbeki believes, nutrition is responsible for AIDS in Africa, why are Kenyans and South Africans in the middle and upper middle classes dying of AIDS?

Don’t they have the best diets and are nutritionally educated?

The rich in Africa should not be dying of AIDS on this basis. Studies show that poor, malnourished children in India, Africa, South America, and Southeast Asia experience shorter courses of infectious diarrhea after taking zinc supplements. Zinc supplements are often given to help heal skin ulcers or bedsores, but they do not increase rates of wound healing when zinc levels are normal.

In any case the cost of anti-retrovirals is now less than Sh6,000 per month, down over 95 per cent a year ago. The proposed cost of the zinc nutrition supplement is Sh300 for three sachets a day which translates to Sh9,000 a month, one half more than the cost of proven, properly tested medicine.

As much as HIV/AIDS has become an industry, now is not the time to challenge the “HIV causes AIDS” theory, not when it has become the single biggest killer of human beings on earth.

Inasmuch as there is much to be done in terms of national response to the AIDS pandemic, we must recognise the steps we have made in recent times. We have maintained the prevalence of AIDS at 14 per cent with positive signs of greater lower prevalence in the near future. This has been due to the concern and involvement of Kenyans and friends of Kenya.

A way forward would be a massive national de-stigmatisation and screening effort. Later supported by the availability of affordable anti-retroviral treatment for those infected. This is the most productive and sustainable solution.

Considering the enormous suffering caused to individuals, families and communities, it is extremely cruel and irresponsible to give HIV/AIDS patients false hopes regarding new treatment unless and until such treatment has been evaluated and found beneficial and efficacious in the hands of several experts.

Kenya AIDS Watch Institute.

 


Back to Top        Back to Home Page

Contact KAWI: webmaster@kawi.org

Kenya AIDS Watch Institute, Woodlands Road, Hurlingham, Nairobi

Tel: 726083/726613,  Fax 726613,  P.O. Box 10013, 00100, GPO, Nairobi, Kenya.